Disclosure Of Cash Flow Statement [Text Block]

Sopharma AD - Filing #6175083

Concept 2022-01-01 to
2022-12-31
As at
2022-12-31
As at
2021-12-31
As at
2020-12-31
Disclosure of cash flow statement [text block]
Description of accounting policy for determining components of cash and cash equivalents [text block]
Cash and cash equivalents if different from statement of financial position [abstract]
Cash and cash equivalents
19 855 BGN
37 722 BGN
Cash and cash equivalents if different from statement of financial position
19 851 BGN
37 717 BGN
25 139 BGN

Talk to a Data Expert

Have a question? We'll get back to you promptly.